КОНСЕРВАТИВНЫЕ МЕТОДЫ ЛЕЧЕНИЯ ПРОЛАПСА ТАЗОВЫХ ОРГАНОВ: СОВРЕМЕННЫЕ ПОДХОДЫ (ОБЗОР)

Библиографические ссылки:

Pelvic Organ Prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2019; 25(6): 397–408. https://doi.org/10.1097/SPV.0000000000000794.

Carberry C.L., Tulikangas P.K., Ridgeway B.M., Collins S.A. et al. American urogynecologic society best practice statement: evaluation and counseling of patients with pelvic organ prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2017; 23(5): 281–287. https://doi.org/10.1097/SPV.0000000000000424

Wu J.M., Vaughan C.P., Goode P.S. et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014; 123(1): 141–148. https://doi.org/10.1097/AOG.0000000000000057

Barber M.D., Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013; 24(11): 1783–1790. https://doi.org/10.1007/s00192-013-2169-9

Российское общество акушеров-гинекологов. Российское общество урологов. Клинические рекомендации: Выпадение женских половых органов. 2024.

Basnet R. Impact of pelvic floor muscle training in pelvic organ prolapse. International Urogynecology Journal. 2021; 32(6): 1351–1360. https://doi.org/10.1007/s00192-020-04613-w

Iglesia C.B., Smithling K.R. Pelvic organ prolapse. Am. Fam. Physician. 2017; 96(3): 179–185. PMID: 28762694.

Ward R.M., Edwards D.R.V., Edwards T. et al. Genetic epidemiology of pelvic organ prolapse: a systematic review. American Journal of Obstetrics and Gynecology. 2014; 211(4): 326–335. https://doi.org/10.1016/j.ajog.2014.04.006

Данилина О.А., Волков В.Г. Факторы риска пролапса тазовых органов у женщин репродуктивного возраста. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2022; 9(2): 111–119. https://doi.org/10.17816/2313-8726-2022-9-2-111-119

Hagen S., Stark D., Glazener C. et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. The Lancet. 2014; 383(9919): 796–806. https://doi.org/10.1016/S0140-6736(13)61977-7

Bø K., Anglès-Acedo S., Batra A. et al. International urogynecology consultation chapter 3 committee 2; conservative treatment of patient with pelvic organ prolapse: pelvic floor muscle training. International Urogynecology Journal 2022; 33(10): 2633–2667. https://doi.org/10.1007/s00192-022-05324-0

Kegel A.H. The nonsurgical treatment of genital relaxation; use of the Perineometer as an Aid in Restoring Anatomic and Functional Structure. Annals of western medicine and surgery. 1948; 2(5): 213–216. PMID: 18860416.

Brækken I.H., Majida M., Engh M.E. et al. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. American Journal of Obstetrics and Gynecology. 2010; 203(2): 170–e1. https://doi.org/10.1016/j.ajog.2010.02.037

Brækken I.H., Majida M., Engh M.E. et al. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstet Gynecol. 2010; 115(2): 317–24. https://doi.org/10.1097/AOG.0b013e3181cbd35f

Fenocchi L., Best C., Mason H. et al. Long-term effects and costs of pelvic floor muscle training for prolapse: trial follow-up record-linkage study. Int Urogynecol J. 2023; 34(1): 239–246. https://doi.org/10.1007/s00192-022-05272-9

Wang X., Qiu J., Li D. et al. Pressure-mediated biofeedback with pelvic floor muscle training for urinary incontinence: A randomized clinical trial. JAMA Network Open. 2024; 7(11): e2442925–e2442925. https://doi.org/10.1001/jamanetworkopen.2024.42925

Höder A., Stenbeck J., Fernando M. et al. Pelvic floor muscle training with biofeedback or feedback from a physiotherapist for urinary and anal incontinence after childbirth - a systematic review. BMC Womens Health. 2023; 23(1): 618. https://doi.org/10.1186/s12905-023-02765-7

Willison N., McPhail C., Seman E. et al. Platelet-Rich Plasma and Fractional CO2 Laser Therapy to Reduce Surgical Intervention for Symptomatic Vaginal Mesh-Related Complications. International Urogynecology Journal. 2025; 1–10. https://doi.org/10.1007/s00192-025-06123-z

Beamish N.F., Davenport M.H., Ali M.U. et al. Impact of postpartum exercise on pelvic floor disorders and diastasis recti abdominis: a systematic review and meta-analysis. British Journal of Sports Medicine. 2025; 59(8): 562–575. https://doi.org/10.1136/bjsports-2024-108619

Alshiek J., Garcia B., Minassian V. et al. Vaginal energy-based devices. Urogynecology. 2020; 26(5): 287–298. https://doi.org/10.1097/SPV.0000000000000872

Рамазанова М.О., Аполихина И.А. Эффективность применения Nd:YAG-лазера (неодимового) при лечении пациенток cо стрессовым недержанием мочи. Медицинский оппонент. 2022; 2(18): 61–64. – EDN FDEPFY.

Giarenis I., Tsiapakidou S., Zacche M. et al. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2024; 299: 342–344. https://doi.org/10.1016/j.ejogrb.2024.05.021

Лапий Г.А., Неймарк А.И., Абдуллаев Н.А.О., Яковлева А.Ю. Влияние Er: YAG-лазера на морфофункциональные изменения стенки влагалища у женщин со стрессовым недержанием мочи. Современные проблемы науки и образования. 2016; 5: 68. – EDN WWVGAN.

Неймарк А.И., Яковлева А.Ю., Лапий Г.А. Результаты лечения стрессового недержания мочи у женщин при помощи Er: YAG-лазера. Урология. 2018; 2: 20–25. https://doi.org/10.18565/urology.2018.2.20-25. – EDN XOTLVZ.

Яковлева А.Ю., Неймарк А.И., Лапий Г.А. Применение лазерных технологий для лечения стрессового недержания мочи у женщин. Journal of Siberian Medical Sciences. 2014; 5: 33. – EDN TABRVV.

Лапий Г.А., Яковлева А.Ю., Абдуллаев Н.А., Неймарк А.И. Патоморфологический анализ применения эрбиевого лазера в коррекции стрессового недержания мочи у женщин. Сибирский научный медицинский журнал. 2018; 38(3): 35–42. https://doi.org/10.15372/SSMJ20180305. – EDN XQOKXB.

U.S. Food and Drug Administration. FDA Safety Communication: Energy-Based Devices for Vaginal “Rejuvenation” and Other Procedures. Silver Spring, MD; 2018.

Mackova K., Van Daele L., Page A.S. et al. Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG. 2020; 127(11): 1338–1346. https://doi.org/10.1111/1471-0528.16273

Machado A.C., Judice L.M.D.P.P., Riccetto C.L.Z., Toledo L.G.M. Applicability of vaginal energy-based devices in urogynecology: evidence and controversy. Rev Assoc Med Bras. 2023; 69 (suppl 1): e2023S129. https://doi.org/10.1590/1806-9282.2023s129

Епифанов В.А., Илларионов В.Е., Жуманова Е.Н. Основная клиническая симптоматика у пациенток с опущением задней стенки влагалища и современные немедикаментозные технологии ее купирования. Физиотерапия, бальнеология и реабилитация. 2018; 17(6): 332–338. https://doi.org/10.17816/1681-3456-2018-17-6-332-338. – EDN GGWOKW.

Vicariotto F., De Seta F., Faoro V. et al. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy. Minerva Ginecol. 2017; 69(4): 342-9. https://doi.org/10.23736/S0026-4784.17.04072-2

Ontario Health (Quality). Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021; 21(3): 1–155. PMID: 34055111; PMCID: PMC8129636

Calles Sastre L., Almoguera Pérez-Cejuela B., Pereira Sánchez A. et al. Complications of pessaries amenable to surgical correction: two case reports and a systematic review of the literature. Journal of Personalized Medicine. 2023; 13(7): 1056. https://doi.org/10.3390/jpm13071056

de Albuquerque Coelho S.C., de Castro E.B., Juliato C.R. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016; 27(12): 1797–1803. https://doi.org/10.1007/s00192-016-2991-y

Sethi N., Yadav G.S. Updates in Pessary Care for Pelvic Organ Prolapse: A Narrative Review. Journal of Clinical Medicine. 2025; 14(8): 2737. https://doi.org/10.3390/jcm14082737

Горбунова Е.А., Ямурзина А.А., Аполихина И.А. Урогинекологические пессарии: практические навыки для врачей. Акушерство и гинекология. 2017; 12: 115–121. https://doi.org/10.18565/aig.2017.12.115-121. – EDN ZWTPML.

Mendes L.C., Bezerra L.R.P.S., Bilhar A.P.M. et al. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users. Int Urogynecol J. 2021; 32(4): 1023–1029. https://doi.org/10.1007/s00192-020-04540-w

Zeiger B.B., da Silva Carramão S., Del Roy C.A. et al. Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life. Int Urogynecol J. 2022; 33(7): 2013–2020. https://doi.org/10.1007/s00192-021-05002-7

van der Vaart L.R., Vollebregt A., Milani A.L. et al. Effect of pessary vs surgery on patient-reported improvement in patients with symptomatic pelvic organ prolapse: a randomized clinical trial. Jama. 2022, 328(23): 2312–2323. https://doi.org/10.1001/jama.2022.22385

Kinjo M., Tanba M., Masuda K. et al. Comparison of effectiveness between modified transvaginal mesh surgery and vaginal pessary treatment in patients with symptomatic pelvic organ prolapse. LUTS: Lower Urinary Tract Symptoms. 2022; 14(1): 64–71. https://doi.org/10.1111/luts.12411

Lone F., Thakar R., Sultan A.H. et al. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. Int J Gynaecol Obstet. 2011; 114(1): 56–9. https://doi.org/10.1016/j.ijgo.2011.02.006

Hooper G.L., Moynihan L., Leegant A. et al. Vaginal pessary use and management for pelvic organ prolapse. Urogynecology. 2023; 29(1): 5–20. https://doi.org/10.1097/SPV.0000000000001293

Lin Y.H., Lim C.K., Chang S.D. et al. Tailor-made three-dimensional printing vaginal pessary to treat pelvic organ prolapse: a pilot study. Menopause. 2023; 30(9): 947–953. https://doi.org/10.1097/GME.0000000000002223

Hong C.X., Zhang S., Eltahawi A. et al. Patient-Specific Pessaries for Pelvic Organ Prolapse Using Three-Dimensional Printing: A Pilot Study. Urogynecology (Phila). 2023; 29(9): 732–739. https://doi.org/10.1097/SPV.0000000000001346

Long J., Zidan G., Seyfoddin A. et al. An estriol-eluting pessary to treat pelvic organ prolapse. Sci Rep. 2022; 12(1): 20021. https://doi.org/10.1038/s41598-022-23791-9

Prodromidou A., Zacharakis D., Athanasiou S. et al. The emerging role on the use of platelet-rich plasma products in the management of urogynaecological disorders. Surgical Innovation. 2022; 29(1): 80–87. https://doi.org/10.1177/15533506211014848

Tappa K., Jammalamadaka U., Ballard D.H. et al. Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study. PLoS One. 2017; 12(8): e0182929. https://doi.org/10.1371/journal.pone.0182929

Pitsillidi A., Vona L., Bettocchi S. et al. PRP Therapy for Stress Urinary Incontinence and Pelvic Organ Prolapse: A New Frontier in Personalized Treatment? Journal of Personalized Medicine. 2025; 15(6): 214. https://doi.org/10.3390/jpm15060214

Kurniawati E.M., Rahmawati N.A., Hardianto G. et al. Role of platelet-rich plasma in pelvic floor disorders: a systematic review. International Journal of Reproductive BioMedicine. 2024; 21(5): 957–974. https://doi.org/10.18502/ijrm.v21i12.15034

Willison N., Behnia-Willison F., Aryan P. et al. Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review. Journal of Clinical Medicine. 2025; 14(16): 5832. https://doi.org/10.3390/jcm14165832

Chen G.D., Oliver R.H., Leung B.S. et al. Estrogen receptor alpha and beta expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Fertil Steril. 1999; 71(6): 1099–102. https://doi.org/10.1016/S0015-0282(99)00113-2

Kashyap R., Jain V., Singh A. Comparison of two pelvic floor muscle training protocols in women with mild prolapse. Int J Gynaecol Obstet. 2013; 121(1): 69–73. https://doi.org/10.1016/j.ijgo.2012.11.012

Blakeman P.J., Hilton P., Bulmer J.N. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 2000; 86(1): 32–8. https://doi.org/10.1046/j.1464-410x.2000.00724.x

Weber M.A., Kleijn M.H., Langendam M. et al. Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. PLoS One. 2015; 10(9): e0136265. https://doi.org/10.1371/journal.pone.0136265

The NICE guideline: Management of pelvic organ prolapse in women. National Institute for Health and Care Excellence 2019. PMID: 31211537.

Kurniawati E.M., Rahmawati N.A., Hardianto G. et al. Role of estrogens in maintenance therapy of patients with pelvic organ prolapse. A systematic review. Russian Bulletin of Obstetrician-Gynecologist. 2024; 24(5): 49–57. https://doi.org/10.17116/rosakush20242405149.

Marschalek M.L., Bodner K., Kimberger O. et al. Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study. BJOG. 2021; 128(13): 2200–2208. https://doi.org/10.1111/1471-0528.16894

Marschalek Marie-Louise, et al. Sexual function in postmenopausal women with symptomatic pelvic organ prolapse treated either with locally applied estrogen or placebo: results of a double-masked, placebo-controlled, multicenter trial. The Journal of Sexual Medicine. 2022; 19(7): 1124–1130. https://doi.org/10.1016/j.jsxm.2022.04.007

Yu X., He L., Wang Y. et al. Local Estrogen Therapy for Pelvic Organ Prolapse in Postmenopausal Women: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022; 51(8): 1728–1740. https://doi.org/10.18502/ijph.v51i8.10255